Skip to main content

Diabetic medicine to publish JBDS guidelines on In-patient diabetes in the Aug 2018

The Joint British Diabetes Societies (JBDS) of which ABCD is an integral member, has informed us of the plans for Diabetic Medicine to devote the August issue to publish the in-patient guidelines and other important papers. This is to be welcomed and will make these very important guidelines to reach readers not only in UK but worldwide.

JBDS VRIII audit

As you will be aware the Joint British Diabetes Society (JBDS) guideline for the use of Variable Rate Intravenous Insulin Infusion (VRIII) was published in late 2014 and we hope it has become firmly embedded in practice in acute trusts throughout the country.

Link to guideline HERE 

East of England Paediatric Diabetes Network - Management of Children and Adolescents with Diabetes Requiring Elective or Emergency Surgery and Other Procedures

During surgery or other procedures under sedation or anaesthesia, the aim is to maintain normal glycaemic control with optimal hydration while preventing hypoglycaemia. These guidelines are based on the International Society of Paediatric and Adolescent Diabetes (ISPAD) clinical practice consensus guidelines. Modifications have been made in the light of recently published adult guidelines and from the guidelines published in the anaesthetic literature. They aim to ensure quality of patient care is standardised but individual units may make adjustments to fit with local practice.

Norfolk and Norwich University Hospitals Trust Guideline for the Management of: Insulin Pump Therapy in Children with Type 1 Diabetes

Norfolk and Norwich University Hospitals NHS Foundation Trust have produced a guideline for the management of insulin pump therapy for children with Type 1 diabetes that covers the following: the process by which suitability for CSII will be determined; the responsibilities of the diabetes team and families, to facilitate effective management of CSII; criteria for discontinuing CSII where its use has not been effective in improving diabetes control and/or quality of life; guidance on management of sick day rules for patients on CSII; insulin pump failure 

Northumbria Diabetes Service CSII Pathway

Northumbria Diabetes Service have developed a care pathway to ensure that all patients considered for pump therapy receive a standardised and documented approach with their multi-disciplinary team through decision making, initiation and follow-up. 

Key to this pathway is their selection process and pre-enrolment discussion and preparation of patients which must fulfill the trust’s referral criteria (including having undertaken a self management course) and be documented in their referral form. 

Making Type 2 diabetes trials more effective – have your say on the most important results of treatment

• A recent systematic review of clinical trials for type 2 diabetes found that no single outcome was measured in all trials. HERE

• A new EU HORIZON 2020 funded study wants to find out what the most important results of treatment for Type 2 diabetes are, to establish a set of minimum core outcomes that should always be measured in Type 2 diabetes research.